A recent study in the journal Radiology suggests that MR spectroscopic imaging at 7.0 T can identify changes in the brains of patients with multiple sclerosis (MS) that were not visible at T1- or T2-weighted MRI. Previous studies have shown that MR spectroscopic imaging (MRSI) allows in vivo assessment of brain metabolism. Also, it is of special interest in MS, where morphologic MRI cannot depict major parts of disease activity.
